Publication | Closed Access
Adjuvant Systemic Chemotherapy with or without Bevacizumab in Patients with Resected Liver Metastases from Colorectal Cancer
24
Citations
18
References
2012
Year
Chemotherapy type and addition of BEV have no impact on both RFS and OS in the adjuvant setting following complete resection of colorectal liver metastases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1